echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > WHO has approved the emergency use of China Kexing Vaccine, the second domestic vaccine has passed the review

    WHO has approved the emergency use of China Kexing Vaccine, the second domestic vaccine has passed the review

    • Last Update: 2021-06-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Yesterday evening, the World Health Organization (WHO) approved the Sinovac vaccine developed by the Chinese company Kexing Pharmaceutical to be added to the emergency use list, making it the seventh new crown vaccine to be certified by WHO for safety, effectiveness and quality.

    It is reported that the WHO independent expert team said in a statement that it is recommended that Kexing's vaccine be used for adults over 18 years of age, and a second injection should be given 2-4 weeks later.
    There is no upper age limit because the data shows that it has a protective effect on the elderly.

    This is the second domestic vaccine that has been urgently approved by the WHO.
    The previous one is the Chinese National Medicine vaccine that was added to the list on May 7.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.